Treatment of Chronic Antibody Mediated Rejection With Intravenous Immunoglobulins and Rituximab: A Multicenter, Prospective, Randomized, Double Blind Clinical Trial

American Journal of Transplantation - United Kingdom
doi 10.1111/ajt.14520

Related search